ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY

Clinical trials for ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY trials appear

Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 6 Terminated 1

Scientists test new combo against tough blood cancers

Disease control Terminated

This early-stage study tested a combination of two drugs, AZD1775 and belinostat, for patients with advanced blood cancers like acute myeloid leukemia (AML) that have returned or not responded to prior treatments. The main goal was to find the safest and most effective dose of th…

Matched conditions: ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY

Get alerted when new ACUTE MYELOID LEUKEMIA POST CYTOTOXIC THERAPY trials appear

Scientists test new combo against tough blood cancers